FDA Inspection 1098849 — Wugan Pharmaceutical (Suzhou) Co., Ltd.
The FDA completed an inspection of Wugan Pharmaceutical (Suzhou) Co., Ltd. on Jul 19, 2019 in Suzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 19, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Suzhou (China)